Cannabis is the most widely used illicit drug in the world, and humans have been using cannabis preparations for thousands of years. It was, however, the discovery of cannabinoid receptors and endogenous cannabinoid molecules in the late 1980s and early 1990s that really sparked the field of cannabinoid pharmacology. Ever since, the (patho)physiology of cannabinoid signaling has been a very active research area, and cannabinoids have been implicated in a wide variety of functions, including learning and memory, mood, movement and pain – as well as disorders in which these functions are disrupted, such as anxiety disorders, depression and addiction.
In order to highlight the diversity and innovation in this research field, we have decided to devote the 2021 Spring Special Issue of Behavioural Pharmacology to Cannabinoids. We therefore invite scientists in the fields of behavioural pharmacology, experimental psychology, behavioural neuroscience and psychiatry, with an active interest in cannabinoids, to submit reports of original, unpublished empirical studies, for inclusion in the Special Issue. Review articles are particularly welcome, but as the Special Issue may include a number of invited reviews, these should be discussed with the Editors at an early stage to avoid duplication. The Editors welcome correspondence from potential authors, so if you are planning to prepare a article for submission, do please let us know. Also, please ask one of the Editors if you are uncertain whether a report of your research would be suitable for inclusion.
All papers should be submitted online at www.editorialmanager.com/bpharm. Contributors are urged to submit as early as possible and should, in any case, aim to do so before the end of July 2020. Later submissions might be accepted, but the later your submission is received, the higher the likelihood that it may miss the publication deadline. We guarantee, however, that any submission that meets quality standards but is accepted too late for inclusion in the Special Issue will be published as soon as possible thereafter.
Louk Vanderschuren (Editor)
Paul Willner (Associate Editor)
Jack Bergman (Associate Editor)
Bart Ellenbroek (Reviews Editor)